1.
Am J Hematol
; 75(2): 92-5, 2004 Feb.
Article
in English
| MEDLINE
| ID: mdl-14755375
ABSTRACT
A case of a patient with chronic myeloid leukemia whose cells expressed an e13a3 (b2a3) variant BCR-ABL p210 mRNA is presented. The variant splice was detected by a qualitative reverse transcriptase polymerase chain reaction using primers complementary to BCR exon 13 (b2) and ABL exon 3 (a3). The patient responded well to imatinib and achieved a complete cytogenetic response.